Sveriges mest populära poddar
Start / PharmaTalkRadio / Microgravity to develop crystalline monoclonal antibodies for subcutaneous

PharmaTalkRadio

Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous

18 min • 2 november 2022
In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.  

Senaste avsnitt

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

14 augusti | 29 min

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min
Vad är en podd?

En liten tjänst av I'm With Friends. Finns även på engelska.

Podcastbild

00:00 -00:00
00:00 -00:00